PASCA, SAMANTHA
 Distribuzione geografica
Continente #
NA - Nord America 3.920
EU - Europa 453
AS - Asia 275
AF - Africa 4
OC - Oceania 3
SA - Sud America 3
Totale 4.658
Nazione #
US - Stati Uniti d'America 3.909
CN - Cina 205
IT - Italia 124
FI - Finlandia 116
GB - Regno Unito 65
VN - Vietnam 53
DE - Germania 41
SE - Svezia 34
FR - Francia 20
UA - Ucraina 16
IE - Irlanda 14
CA - Canada 10
RU - Federazione Russa 6
HK - Hong Kong 5
IN - India 5
BG - Bulgaria 3
CH - Svizzera 3
ES - Italia 3
NL - Olanda 3
TN - Tunisia 3
AU - Australia 2
GR - Grecia 2
KR - Corea 2
TR - Turchia 2
AT - Austria 1
BR - Brasile 1
BY - Bielorussia 1
CL - Cile 1
JP - Giappone 1
MA - Marocco 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
Totale 4.658
Città #
Fairfield 808
Woodbridge 365
Houston 280
Ashburn 270
Seattle 263
Ann Arbor 261
Cambridge 233
Wilmington 194
San Diego 179
Medford 166
Princeton 166
Roxbury 141
Chandler 121
Des Moines 120
Helsinki 91
Guangzhou 66
Dong Ket 53
Shanghai 46
Beijing 36
Boardman 20
Padova 20
New York 18
London 17
Dublin 14
Nanjing 14
Kharkiv 13
Borås 11
Ogden 10
Brendola 9
Norwalk 9
Hounslow 7
Milan 7
Nanchang 7
Naples 7
Turin 7
Redmond 5
Southwark 5
Trieste 5
Cagliari 4
Hong Kong 4
Kilburn 4
Rockville 4
Shenyang 4
Campobasso 3
Fremont 3
Las Vegas 3
Rome 3
Sofia 3
Venice 3
Amsterdam 2
Ansbach 2
Bari 2
Castel Gabbiano 2
Catanzaro 2
Chiswick 2
Dallas 2
Duino-Aurisina 2
Hebei 2
Kansas City 2
Marseille 2
Messina 2
Mezzano 2
Mykolayiv 2
Newcastle upon Tyne 2
Palermo 2
Paris 2
Pescara 2
Pomezia 2
Prescot 2
Pune 2
Pátrai 2
Redwood City 2
Rovereto 2
San Giovanni Rotondo 2
Seoul 2
Stoke-on-Trent 2
Storo 2
Tianjin 2
Toronto 2
Trento 2
Villeurbanne 2
Washington 2
Alliston 1
Apex 1
Bangkok 1
Berlin 1
Boisar 1
Bologna 1
Bolzano 1
Bridgewater 1
Brighton 1
Brolo 1
Casavatore 1
Cassino 1
Central 1
Centralia 1
Changzhou 1
Chioggia 1
Columbus 1
Concepción 1
Totale 4.186
Nome #
Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry 100
Fondaparinux in the initial and long-term treatment of venous thromboembolism 98
Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs 96
Acute venous thromboembolism after non-major orthopaedic surgery or post-traumatic limb immobilisation 94
Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry 92
Tailored prophylaxis with rFXIII (NovoThirteen ® ) in a young girl with severe FXIII deficiency and previous cephalohaematoma 89
Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism 86
A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. 85
Factors Associated with elevated Pulmonary Arterial Pressure Levels on the Echocardiographic Assessment in Patients with Prior Pulmonary Embolism 84
Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism 83
Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism 80
Clinical presentation and outcome of venous thromboembolism in COPD 79
Unsuspected pulmonary embolism in patients with cancer 77
D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer 73
Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry. 70
null 64
Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®) 63
Influence of recent immobilization and recent surgery on mortality in patients with pulmonary embolism 62
Clinical significance of a negative D-dimer level in patients with confirmed venous thromboembolism. Findings from the RIETE Registry 60
Platelet count and outcome in patients with acute venous thromboembolism 59
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 59
Activated prothrombin complex concentrate (FEIBA ® ) in acquired haemophilia A: a large multicentre Italian study – the FAIR Registry 58
Low-molecular-weight or Unfractionated Heparin in Venous Thromboembolism: The Influence of Renal Function 56
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism 54
La patologia cerebro e cardiovascolare nel paziente emofilico adulto dall’epidemiologia al trattamento. Registro multicentrico, retrospettivo-prospettico. 53
Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis 52
Outcomes in Neurosurgical Patients Who Develop Venous Thromboembolism: A Review of the RIETE Registry 50
ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers 50
Regenerative Surgery with Dental Implant Rehabilitation in a Haemophiliac Patient 47
Usefulness of Thrombophilia Testing in Venous Thromboembolic Disease: Findings From the RIETE Registry 46
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity 46
Immunosuppression for acquired hemophilia A: Results from the European Acquired Haemophilia Registry (EACH2) 45
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report 43
Cerebrovascular diseases in hemophiliacs: A real, but underestimated risk 41
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 41
PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A 40
Prothrombin complex concentrate such as therapy and prophylaxis in factor X-deficient patient (Friuli Variant) 40
Cancers in patients with hemophilia: A retrospective study from the Italian Association of Hemophilia Centers 39
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study 37
Regenerative Surgery with Dental Implant Rehabilitation in a Haemophiliac Patient 37
Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study 37
The Italian START-Register on anticoagulation with focus on atrial fibrillation 35
Can the plasmaderived factor VIII still play a role in the treatment of acquired hemophilia A at the time of new drugs? 35
Coagulation and oxidative stress plasmatic levels in a type 2 diabetes population 34
Long-term anticoagulant therapy of patients with venous thromboembolism. What are the practices? 34
Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry 33
Aspirin for preventing the recurrence of venous thromboembolism 33
Venous thromboembolism during pregnancy, postpartum or during contraceptive use: Findings from the RIETE Registry 32
Use of recombinant activated factor VII in severe post-partum haemorrhage: Data from the Italian Registry. A multicentric observational retrospective study 32
16. The real-life use of rFXIII (catridecacog) in patients with severe Factor XIII deficiency: an Italian survey. 31
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs 31
Clinical characteristics and outcome of inpatients versus outpatients with venous thromboembolism: Findings from the RIETE Registry 31
Major bleeding as a predictor of mortality in patients with venous thromboembolism: Findings from the RIETE Registry 31
Efficacy and safety of peripheral blood stem cell mobilization and collection: A single-center experience in 190 allogeneic donors 30
Successful double bypass in a patient with severe hemophilia A: A case report 30
Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism 30
Demographic and clinical data in acquired hemophilia A: Results from the European Acquired Haemophilia Registry (EACH2) 30
Bleeding complications associated with anticoagulant therapy in patients with cancer 29
Pregnancy-associated acquired haemophilia A: Results from the European Acquired Haemophilia (EACH2) registry 29
Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT Registry 28
D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE registry 28
Extended Compression Ultrasound Performed by Emergency Physicians: A Modified Compression Ultrasound Examination to Detect Superficial and Deep Lower Limb Thromboses in the Emergency Department 28
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism 27
Management of bleeding in acquired hemophilia A: Results from the European Acquired Haemophilia (EACH2) registry 27
Recurrent venous thromboembolism in anticoagulated patients with cancer: Management and short-term prognosis 27
The international factor IX treatment network survey 26
Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres 26
Haemophilia A/B carriers: haemorrhagic burden of disease and open issues 26
Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study 26
An Italian Survey on the real-world use of rFXIII (catridecacog) in patients with factor XIII deficiency 26
Treatment With Efmoroctocog Alfa (Elocta®) in Hemophilia: A Case Series 26
Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency 26
Gender differences in cancer patients with acute venous thromboembolism 25
Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: The history of a success 24
Retinal vein occlusion: Evaluation of "classic" and "emerging" risk factors and treatment 24
Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry 24
Thrombophilic mutations as risk factor for retinal vein occlusion: A case-control study 23
PdFVIII/VWF may be an alternative treatment for old medical patient with acquired haemophilia A and systemic vascular disease? 23
Vanishing bile duct syndrome in non-Hodgkin lymphoma: a case report 23
Direct Oral Anticoagulants for Very Elderly People with Atrial Fibrillation: Efficacy and Safe Enough? 23
Safety and efficacy of thromboprophylaxis with fondaparinux in elderly acutely ill medical patients with renal impairment: a retrospective single center study 23
Long-term outcomes of patients with cerebral vein thrombosis: A multicenter study 23
Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A 22
Practical use of intermittent pneumatic compression as thromboprophylaxis in neurosurgery 22
Adult patients with mild haemophilia: an under-valued population, but at high risk for intracranial haemorrhage (data from the EMO.REC Registry). 22
Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: A multicenter cohort study 22
Use of Recombinant Activated Factor VII in Severe Post-Partum Haemorrhage: Data from the Italian Registry. A Multicentric Observational Retrospective Study. 22
Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs 21
Identification of low-risk patients with acute symptomatic pulmonary embolism for outpatient therapy 21
Spontaneous recurrent intracranial haemorrhage in a woman with type 2B von Willebrand disease: A clinical case and a brief literature review 20
Venous thromboembolism in patients immobilised at home 20
Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry 19
An Italian Survey on the real-world use of rFXIII (catridecacog) in patients with Factor XIII deficiency. 19
Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: The SHAPE Study 18
Caesarean surgery or vaginal delivery in a pregnant woman with homozygous FXI deficiency and FXI level <1%? This is the question! 18
The sudden and unexpected appearance of inhibitors in a previously treated severe haemophilia B patient after the switch to albutrepenonacog alpha 18
Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience 17
Final data from the Italian Registry on intracranial haemorrhage in haemophilia patients: EMO.REC Registry (2009-2018). 17
High risk of intracranial haemorrhage in adult mild haemophiliac patients: data from the EMO.REC Registry. 17
Immune tolerance induction rescue (ITI-R) with human-cl rhFVIII in haemophilia A patients and high-titre inhibitors. 17
Totale 4.069
Categoria #
all - tutte 26.755
article - articoli 26.576
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019174 0 0 0 0 0 0 0 0 0 0 99 75
2019/2020378 63 17 2 24 56 34 45 46 51 19 10 11
2020/2021679 7 18 1 30 6 1 10 27 277 62 21 219
2021/20222.112 65 83 251 123 422 90 134 160 165 33 123 463
2022/2023649 286 12 7 18 70 75 10 37 73 10 32 19
2023/2024505 12 46 39 55 51 59 43 32 31 135 2 0
Totale 4.892